Whalesbook
Deterioration in Quarterly Performance
Tata Chemicals Ltd. reported a substantial net loss of ₹2,132 crore for the fourth quarter ended March 31, marking a sharp decline from a ₹56 crore loss in the same period last year. This widening deficit occurred despite a marginal 2% year-on-year decrease in revenue, which stood at ₹3,438 crore.
Margin Pressure and Segmental Woes
Operating performance mirrored the net loss, with EBITDA falling 16.2% to ₹274 crore. Consequently, profit margins compressed to 7.97% from 9.32% in the prior year. The company's fundamental basic chemistry business bore the brunt of this pressure, with revenues declining and the segment swinging to a loss of ₹1,802 crore, a significant reversal from a profit in the previous year. Conversely, the specialty products segment showed resilience, with revenue growth and a reduction in losses.
Investor Returns and Future Investments
Despite the weak financial results, the board has proposed a dividend of ₹11 per share (110%) for the fiscal year 2026, pending shareholder approval. This move signals a commitment to returning value to shareholders. Additionally, the company greenlit an investment of ₹100 crore to expand its iodised vacuum salt production capacity at the Mithapur plant. This expansion aims to increase capacity by 82,500 tonnes per annum over the next 12 months to cater to rising market demand.